. Patients included in this study having acute ST elevation myocardial infarction admitted in hospital within 12 hours of onset of symptoms. Patients excluded from study were those, who had conventional contraindications for thrombolytic. Sample size of this study was considered eighty. The sample size was selected purposively. A questionnaire was prepared on the basis of history, clinical examination, risk factors and socio-demographic characteristics. A check list was prepared on the basis of serial ECG recordings for up to 180 minutes and follow up of every patient for up to 6 weeks. Among these, ST-segment resolution at 90 minutes in ECG was the principal determinant of this study. Relevant data's were collected by taking detailed history and doing physical examination of selected patients. Age, gender, risk factors were determined. Pulse, blood pressure, heart and lungs were examined and killip class determined in every patient. Standard 12 lead ECG was recorded in all patients. The ECG findings emphasized on rate, rhythm, QRS axis, PR interval, QRS duration, voltage criteria, R wave, Q wave, changes in ST segment and in T waves. Patients having acute ST-segment elevation of ≥1mm in at least 2 limb leads or ST-segment elevation of ≥2 mm in ≥2 contiguous precordial leads were included in this study. After administration of streptokinase, ECG was done at 30 minutes, 60 minutes, 90 minutes and 180 minutes to see whether ST segment resolution occurs or not. ST segment resolution was set as 50 % or more fall of elevated ST segment from baseline value within 90 minutes of starting streptokinase. Study cases were divided into two groups on the basis of ST segment resolution. ST segment resolved group and ST segment non resolved group. Streptokinase was administered to all included patients. All studied cases were followed up for up to six weeks from the time of enrollment into study. 
was intensively examined in hospital from admission to discharge. All patients were closely observed to detect whether any serious complications like arrhythmia, heart failure and reinfarction developed or not. After discharge patients were visited on 15th, 30th and 45th day and patients who did not visit hospital, information's were collected over telephone. Mortality status was done in relation to ST segment resolution. Data obtained from study was analyzed and significance of difference was estimated by using the statistical methods. Data's were expressed in frequency, percentage, mean and standard deviation as applicable. Comparison between groups was done by student 't' test, chi-square test and multivariate analysis as applicable. Variables with a p-value of <0.05 was counted as significant and p-value of > 0.05 was counted as insignificant. All statistics were calculated with SPSS software version 11.0 
Results

:
Risk factors
Discussion:
Studied populations were in the age range of 25-70 years. Most of the patients were between 50 to 70 yrs. Male female ratio of patients were 12.33:1. 76% patients were smoker. Smoking was more commonly found risk factor followed by dyslipidemia, obesity, hypertension and diabetes among studied populations. Inferior M.I. was commonly found in enrolled patient, which was 37.5% followed by anterior M.I. found in 22.5% patients. Clinical characteristics were evaluated in study population according to ST-Segment resolution at 90 minutes. Median age was 50 in both ST segment resolved group and ST-segment non resolved group. 94% patients were male in ST-segment resolved group. Smoking was the most common risk factor in both group. Hypertension, diabetes mellitus, dyslipidemia and obesity were more prevalent in patients with non resolved ST-segment group. Anterior wall myocardial infarction was more common in patients with ST-segment resolved group. Time interval between onset of symptoms of acute myocardial infarction and starting of streptokinase was 360 minutes in patients with non resolved ST segment group and it was 300 minutes in patients with ST segment resolved group. Killip class >1 was present in 18% patient with ST-segment resolved group and in 24% patient with non resolved ST-segment group. P value is not significant in any variables. After administration of streptokinase ST segment was resolved in 59 patients, that is STsegment resolution of ≥50% occurred at 90 minutes in these patients and ST segment was not resolved in 21 patients. Among ST segment resolved group early mortality was only 1.7 percent and early mortality was 57.1 percent in non resolved ST segment group, which is highly significant with a P value of <0.001. In ASSENT trial early mortality was 1.4%. 13 The mean symptom duration was 168 min in our study compared to 357 min in the single-centre study. 14 ST-segment resolution at 90min was in the present study independently associated with higher early mortality as in previous studies. 15 In this study death rate was higher in patients received streptokinase after 6 hours of onset of symptoms than in patients who received within 6 hours of symptoms (54% versus 46%). Patients without very early signs of reperfusion but with a short symptom duration of less than 2 hours and more frequently achieved ST-segment resolution at least within 180 min, which has been previously associated with a smaller infarct size and better outcome. 16 Hence this might indicate a greater extent of myocardial salvage as a result of shorter time to therapy. However, only one large study has been able to show independent prognostic value of both symptom duration and late ST-segment resolution after adjusting for other risk factors. 17 ST segment resolution was less likely to be achieved in the troponin I positive compared to the troponin I negative patients. This relation has previously been shown only in a small study by Frostfeldt et al, where the percentage ST segment resolution was less in the group with troponin I elevation. 18 Several studies have shown that ST-segment resolution is a more sensitive marker of tissue level reperfusion than of epicardial flow. However, the fact that no ST resolution at 90min was independently related to higher early mortality. Time to ST segment resolution also suggest complementary pathophysiological mechanisms concerning their relation to early mortality. ST segment resolution measures the effect of treatment on tissue level reperfusion and subsequent myocardial salvage. As in previous trials, the variables e.g. age, heart rate and systolic BP constituting the risk index proposed by Morrow et al, were strong independent predictors of early mortality. 19 Length of study was calculated only in patients who survived to hospital discharge. Overall median length of hospital stay was two days greater in non resolved ST segment group than in successfully thrombolysed group (9 days versus 7 days). Patients who did not experience an adverse event in the first 72 hours after admission remained event free subsequently while in hospital. From the GUSTO-1 population, it has been shown that electrocardiographic signs of reocclusion, i.e. ST-elevation, 6-24 hours after thrombolysis, predicts worse prognosis. 20 Furthermore, it is previously seen in ASSENT trial that even very small variations of the ST-segment during first 4 hours of observation have a negative effect on 30 day and 1 year outcome. A rational way to use this information in the clinical setting would be to continuously risk-stratify the patient. Our data suggest that a first evaluation of treatment can be done. And support for clinical decision making may already be available at 90 minutes. If the patient reached 50% ST-resolution, myocardial flow is most probably restored and the patient belongs to low risk group. If not, it may time to prepare further invasive or pharmacological treatment. This study highlights the poor clinical outcome of patients with ST-segment non resolution after thrombolytic treatment, indicated by simple evaluation of the post thrombolysis electrocardiogram.
Conclusion:
Stratifying the risk in patients with acute myocardial infarction is an essential part of the management strategy during all phases of care of these patients. It permits not only the more precise calibration of treatment and diagnostic approaches with the level of risk but also increasingly facilitate the appropriate utilization of hospital resources. Continuous ST-monitoring of patients with acute myocardial infarction yields important prognostic information after 90 min of observation and should be used for very early risk stratification and supports a future basis for individualized treatment of these patients.
ST segment resolution at 90 minutes are strong predictors of early mortality and gives additive early information about prognosis and further improves risk stratification in acute STEMI. An approach for risk stratification and treatment strategy can be suggested from our findings:
No ST segment resolution indicative of failed epicardial and/or tissue level reperfusion. These patients have a high mortality risk.
An early ST-resolution as indicated by ST-segment resolution at 90 minutes are at low risk. Thus there treatment seems sufficient.
